Part 1 - Welcome address by Dr. Shikha Verma, Lupin Oncology
Part 2 - Introduction by Dr. M B Agarwal, Mumbai
Part 3 - Lymphoma: Article review - Dr. Sandeep Jasuja, Jaipur
Part 4 - Ibrutinib maintenance in MCL - Dr. Sanjeev, Luknow
Part 5 - Immune - Checkpoint inhibitors in NHL - Dr. Dinesh Bhurani, Delhi
Part 6 - Harnessing lymphoma epigenetics to improve therapies - Dr. Hari Menin, Bengaluru
Part 7 - Aggressive Lymphomas: What novel approaches are ready to address - Dr. Ganesh Jaishetwar
Part 8 - Discussion (Lymphoma: Article review) - Dr. Sandeep Jasuja
Part 9 - Myeloma: Article review - Brig (Dr) Satyaranjan Das, Pune
Part 10 - Future of immunotherapy in myeloma - Dr Sandip Shah, Ahmedabad
Part 11 - Thrombosis in myeloma - Dr Mukul Aggarwal, Delhi
Part 12 - Outdoor transplants in Covid-19 era - Dr. Sharat Damodar, Bengaluru
Part 13 - Discussion (Myeloma: Article review) - Brig (Dr) Satyaranjan Das, Pune
Part 14 - Vote of Thanks - Dr. Shikha Verma, Lupin Oncology
